Mostrando 241 - 260 Resultados de 16,624 Para Buscar '"hepatitis B"', tiempo de consulta: 2.57s Limitar resultados
  1. 241
    “…Hepatitis B is a major global health problem with high morbidity and mortality. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 242
    “…The development of anti-HBe antibody in hepatitis B patients usually correlates with reduction of HBV viremia. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  3. 243
    por Hou, Jinlin, Liu, Zhihua, Gu, Fan
    Publicado 2005
    “…Hepatitis B is one of the most common infectious diseases globally. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  4. 244
  5. 245
    “…Chronic hepatitis B virus (HBV) infection is one of the leading causes of liver cirrhosis and hepatocellular carcinoma (HCC). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  6. 246
    “…Entecavir (ETV) is a potent and selective inhibitor of hepatitis B virus replication. In HBeAg-positive and HBeAg-negative lamivudine-naïve patients with chronic hepatitis B (CHB), treatment with ETV at a dose of 0.5 mg daily is associated with a more potent viral suppression, a higher rate of biochemical remission and a greater improvement of liver histology compared to Lamivudine (LAM). …”
    Enlace del recurso
    Enlace del recurso
    Texto
  7. 247
    por Krugman, S., Davidson, M.
    Publicado 1987
    “…The duration of hepatitis B vaccine-induced immunity was studied in a group of 54 seronegative health professionals who received plasma-derived hepatitis B vaccine (Merck's Heptavax) in 1978 and 1979. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  8. 248
    por Desmet, V. J.
    Publicado 1988
    “…A review is made of the various histological lesions observed in hepatitis B virus-related liver diseases, including different forms of acute and chronic hepatitis, cirrhosis, and hepatocellular carcinoma. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  9. 249
    “…BACKGROUND: Occult or latent hepatitis B virus (HBV) infection is defined as infection with detectable HBV DNA and undetectable surface antigen (HBsAg) in patients' blood. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  10. 250
    “…BACKGROUND: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are important causes of morbidity and mortality of hemodialysis (HD) patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  11. 251
  12. 252
  13. 253
    por Lim, Young-Suk, Suh, Dong Jin
    Publicado 2004
    “…During the past decade, major breakthroughs have been achieved in treatment of chronic hepatitis B. Currently, three therapeutic agents are approved for chronic hepatitis B: interferon-alpha, lamivudine and adefovir dipivoxil. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  14. 254
    por Poordad, Fred, Chee, Grace M.
    Publicado 2010
    “…Hepatitis B is a DNA virus affecting hundreds of millions of individuals worldwide. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  15. 255
  16. 256
  17. 257
  18. 258
    por Song, H. K., Kim, H. C., Yun, Y. H.
    Publicado 1997
    “…We report a case of myelitis after plasma-derived hepatitis B vaccination. The patient was a 31-year-old man who presented with progressive sensory symptoms in extremities that developed 2 weeks after a third vaccination. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  19. 259
    por Wong, CH, Goh, KL
    Publicado 2006
    “…Hepatitis B virus (HBV) is one of the most well recognised human carcinogens. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  20. 260
Herramientas de búsqueda: RSS